Importance Medication for opioid use disorder (MOUD) is the criterion standard treatment for
opioid use disorder (OUD), but nationally representative studies of MOUD use in the US are …

Opioid overdose deaths remain a major public health crisis. We used a system dynamics
simulation model of the US opioid-using population age 12 and older to explore the impacts …

Importance Local-level data are needed to understand whether the relaxation of X-waiver
training requirements for prescribing buprenorphine in April 2021 translated to increased …

Importance Buprenorphine is underutilized as a treatment for opioid use disorder (OUD);
state policies may improve buprenorphine access and utilization. Objective To assess …

Abstract Background In the United States, an x‐waiver credential is necessary to prescribe
buprenorphine medication treatment for opioid use disorder (B‐MOUD). Historically, this …

Importance Buprenorphine treatment for opioid use disorder (OUD) is associated with
decreased morbidity and mortality. Despite its effectiveness, buprenorphine uptake has …

Abstract Aims, Design and Setting We sought to describe longitudinal trends in
buprenorphine receipt and buprenorphine‐waivered providers in the United States from …

Background Many active buprenorphine prescribers treat few patients monthly, but little
information is available regarding how prescribers' buprenorphine caseload fluctuates over …

Background: Increasing buprenorphine access is critical to facilitating effective opioid use
disorder treatment. Buprenorphine prescriber numbers have increased substantially, but …

Introduction Buprenorphine can only be prescribed for opioid use disorder (OUD) by
providers with a Controlled Substance Act waiver (X waiver) from the Substance Abuse and …